Skip to main content

CITADEL ADVISORS LLC

Position in MESO — Mesoblast Ltd

CIK 1423053 MIAMI, FL

Position in MESO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,322,049
-$1,048,189 QoQ
Shares Held
85,959
-34.6% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Derivatives in MESO

reported options exposure · as of Mar 31, 2026
CallValue
$6,433,454
CallShares
418,300
PutValue
$632,118
PutShares
41,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. MESO ranks #220 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MESO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $632,118 41,100
2026-03-31 $6,433,454 418,300
2026-03-31 $1,322,049 85,959
2025-12-31 $2,370,238 131,388
2025-12-31 $561,044 31,100
2025-12-31 $8,444,524 468,100
2025-09-30 $3,702,078 229,800
2025-09-30 $1,064,871 66,100
2025-06-30 $812,786 74,636
2025-06-30 $690,426 63,400
2025-06-30 $1,539,301 141,350
2025-03-31 $1,883,856 150,950
2025-03-31 $6,075,176 486,793
2025-03-31 $1,032,096 82,700
2024-12-31 $5,719,230 288,850
2024-12-31 $2,309,670 116,650
2024-09-30 $1,238,572 151,600
2024-09-30 $326,538 39,968
2024-09-30 $424,023 51,900
2024-06-30 $682,702 100,250
2024-06-30 $526,372 77,294
2024-06-30 $364,335 53,500
2024-03-31 $121,743 24,300
2024-03-31 $277,053 55,300